June 28, 2022
The behind-the-scenes, yet powerful companies who control patients’ access to drugs may soon have to answer for their tactics.
June 24, 2022
In a victory for patient protections, a federal appellate court upheld a West Virginia law designed to put guardrails on unscrupulous “bad drug” advertising.
February 17, 2022
Patients, alongside their health care providers, should decide which medication is right for them. Yet, with increasing frequency, that decision is being overruled by “the middleman.”
August 20, 2019
Medicare beneficiaries nationwide will soon have coverage for cutting-edge CAR-T cancer therapy, the Centers for Medicare and Medicaid Services announced this month.
July 25, 2019
Access to hepatitis C cures isn’t just saving lives. It’s saving money for cash-strapped Medicaid systems.
June 7, 2019
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
May 29, 2019
Cancer patients are breathing a sigh of relief. So are patients with movement disorders. And those with epilepsy, HIV and…
February 19, 2019
Add movement disorders patients to the long list of people whose health could suffer under the Trump administration’s proposal to…
December 17, 2018
The newest proposal to cut prescription drug costs could strip important protections for already vulnerable patients, especially those living in long-term care facilities.
November 14, 2018
A new white paper from the Congressional Diabetes Caucus reinforces what patients and advocates know all too well — the insulin pricing system is too complicated, the negotiations are too secretive and the cost for patients is too high.
